Bivatuzumab mertansine

Source: Wikipedia, the free encyclopedia.
Bivatuzumab mertansine
Humanized (from mouse)
TargetCD44 v6
Clinical data
ATC code
  • none
Identifiers
ChemSpider
  • none
 ☒NcheckY (what is this?)  (verify)

Bivatuzumab mertansine is a combination of

squamous cell carcinoma.[1]

References